BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24062991)

  • 1. PML in the Brain: From Development to Degeneration.
    Korb E; Finkbeiner S
    Front Oncol; 2013 Sep; 3():242. PubMed ID: 24062991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cognitive function and reduced anxiety-related behavior in a promyelocytic leukemia (PML) tumor suppressor protein-deficient mouse.
    Butler K; Martinez LA; Tejada-Simon MV
    Genes Brain Behav; 2013 Mar; 12(2):189-202. PubMed ID: 23279884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.
    Guion LG; Sapp M
    Front Cell Infect Microbiol; 2020; 10():35. PubMed ID: 32154186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?
    Borden KL
    Biochim Biophys Acta; 2008 Nov; 1783(11):2145-54. PubMed ID: 18616965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and regulation of PML bodies in the adult mouse brain.
    Hall MH; Magalska A; Malinowska M; Ruszczycki B; Czaban I; Patel S; Ambrożek-Latecka M; Zołocińska E; Broszkiewicz H; Parobczak K; Nair RR; Rylski M; Pawlak R; Bramham CR; Wilczyński GM
    Brain Struct Funct; 2016 Jun; 221(5):2511-25. PubMed ID: 25956166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-regulated cytoskeleton-associated protein Arc/Arg3.1 binds to spectrin and associates with nuclear promyelocytic leukemia (PML) bodies.
    Bloomer WA; VanDongen HM; VanDongen AM
    Brain Res; 2007 Jun; 1153():20-33. PubMed ID: 17466953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear bodies inside out: PML conquers the cytoplasm.
    Carracedo A; Ito K; Pandolfi PP
    Curr Opin Cell Biol; 2011 Jun; 23(3):360-6. PubMed ID: 21501958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular biology of acute promyelocytic leukemia.
    Slack JL; Gallagher RE
    Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
    Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
    Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trivalent antimonials induce degradation of the PML-RAR oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells.
    Müller S; Miller WH; Dejean A
    Blood; 1998 Dec; 92(11):4308-16. PubMed ID: 9834237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advances on function of promyelocytic leukemia (PML) protein].
    He PC; Zhang M; Wang F
    Ai Zheng; 2003 Dec; 22(12):1359-62. PubMed ID: 14693070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The function, regulation and therapeutic implications of the tumor suppressor protein, PML.
    Guan D; Kao HY
    Cell Biosci; 2015; 5():60. PubMed ID: 26539288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
    Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
    J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promyelocytic (PML) nuclear compartment and transcription control.
    Doucas V
    Biochem Pharmacol; 2000 Oct; 60(8):1197-201. PubMed ID: 11007958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
    Patra U; Müller S
    Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
    Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
    Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcript isoforms of promyelocytic leukemia in mouse male and female gametes.
    Ebrahimian M; Mojtahedzadeh M; Bazett-Jones D; Dehghani H
    Cells Tissues Organs; 2010; 192(6):374-81. PubMed ID: 20664248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-translational Modifications of PML in Regulating the Functions of Nuclear Bodies --Review].
    Ma XF; Tan Y; Li SF; Jin W; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1696-1700. PubMed ID: 31607334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
    Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.